Dynamic Technology Lab Private Ltd Grows Holdings in athenahealth, Inc. (ATHN)
Dynamic Technology Lab Private Ltd grew its holdings in athenahealth, Inc. (NASDAQ:ATHN) by 72.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,440 shares of the health services provider’s stock after purchasing an additional 2,711 shares during the quarter. Dynamic Technology Lab Private Ltd’s holdings in athenahealth were worth $800,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in ATHN. Turner Investments LLC acquired a new stake in shares of athenahealth during the 2nd quarter worth approximately $105,000. Bessemer Group Inc. increased its holdings in shares of athenahealth by 13.7% during the 2nd quarter. Bessemer Group Inc. now owns 938 shares of the health services provider’s stock worth $132,000 after buying an additional 113 shares during the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of athenahealth by 7.7% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock worth $166,000 after buying an additional 84 shares during the last quarter. Seven Bridges Advisors LLC increased its holdings in shares of athenahealth by 5.4% during the 2nd quarter. Seven Bridges Advisors LLC now owns 1,303 shares of the health services provider’s stock worth $183,000 after buying an additional 67 shares during the last quarter. Finally, BNP Paribas Arbitrage SA increased its holdings in shares of athenahealth by 123.8% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 1,345 shares of the health services provider’s stock worth $189,000 after buying an additional 744 shares during the last quarter.
Shares of athenahealth, Inc. (NASDAQ ATHN) opened at $130.23 on Friday. athenahealth, Inc. has a 1-year low of $90.11 and a 1-year high of $158.66. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.67 and a quick ratio of 1.67. The firm has a market cap of $5,211.50, a P/E ratio of 110.36, a P/E/G ratio of 5.04 and a beta of 1.57.
athenahealth (NASDAQ:ATHN) last posted its quarterly earnings results on Thursday, October 19th. The health services provider reported $0.56 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The company’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.60 earnings per share. equities analysts expect that athenahealth, Inc. will post 1.16 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This story was reported by Watch List News and is owned by of Watch List News. If you are accessing this story on another domain, it was illegally stolen and republished in violation of international trademark & copyright legislation. The original version of this story can be viewed at https://www.watchlistnews.com/dynamic-technology-lab-private-ltd-grows-holdings-in-athenahealth-inc-athn/1722983.html.
In other athenahealth news, CEO Jonathan Bush sold 4,000 shares of the business’s stock in a transaction on Friday, September 1st. The shares were sold at an average price of $139.77, for a total value of $559,080.00. Following the completion of the transaction, the chief executive officer now owns 319,807 shares in the company, valued at $44,699,424.39. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Brandon H. Hull sold 800 shares of the business’s stock in a transaction on Monday, November 20th. The stock was sold at an average price of $130.00, for a total transaction of $104,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 13,283 shares of company stock valued at $1,741,372. Insiders own 3.20% of the company’s stock.
A number of brokerages have recently issued reports on ATHN. Cantor Fitzgerald restated a “hold” rating and set a $120.00 price target on shares of athenahealth in a report on Friday, October 27th. SunTrust Banks, Inc. restated a “buy” rating and set a $156.00 price target on shares of athenahealth in a report on Wednesday, October 25th. Leerink Swann cut their price target on shares of athenahealth from $155.00 to $125.00 and set a “market perform” rating for the company in a report on Monday, October 23rd. Wells Fargo & Co cut their price target on shares of athenahealth from $190.00 to $155.00 and set an “outperform” rating for the company in a report on Monday, October 23rd. Finally, Canaccord Genuity restated a “hold” rating and set a $123.00 price target (down previously from $144.00) on shares of athenahealth in a report on Monday, October 23rd. Two equities research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and eleven have given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $143.22.
athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.
Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).
Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.